{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:41:33Z","timestamp":1792611693595,"version":"4.5.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>This report describes a rare case of neuromyelitis optica spectrum disorder (NMOSD) complicated by systemic capillary leak syndrome (SCLS) and reviews the literature to examine the clinical features, pathogenesis, and therapeutic implications of autoimmune disease\u2013associated SCLS. A 20-year-old woman with NMOSD developed sudden-onset SCLS, presenting with hypotension, hemoconcentration (hematocrit 58.7%), hypoalbuminemia (26 g\/L), and pulmonary edema after initial immunotherapy. Cardiogenic and septic shock, as well as pulmonary embolism, were excluded, leading to a diagnosis of SCLS. Intensive treatment with albumin replacement, thoracic drainage, and intravenous immunoglobulin (IVIG, 0.4 g\/kg\/day) stabilized her condition. Maintenance therapy with satralizumab, an anti\u2013interleukin-6 receptor monoclonal antibody, achieved sustained remission over 1 year. A review of 12 cases (including this case) identified autoimmune diseases\u2014most commonly Sj\u00f6gren\u2019s syndrome (41.7%) and NMOSD (16.7%)\u2014as frequent SCLS comorbidities. Infections (33.3%) and autoimmune flares (25%) were the most common triggers. Multimodal therapy combining glucocorticoids and IVIG, with or without additional immunosuppressants, resulted in clinical improvement in 75% of cases. This report emphasizes that SCLS is a life-threatening complication of autoimmune diseases, particularly NMOSD. Autoimmune disease relapses and infections are common precipitating factors. Prompt diagnosis and intervention are critical. Satralizumab warrants further investigation as a potential therapeutic option for this rare comorbidity.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1684380","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T07:00:18Z","timestamp":1772607618000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Rare co-occurrence of NMOSD and capillary leak syndrome treated with satralizumab"],"prefix":"10.3389","volume":"17","author":[{"given":"Juanjuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guogao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1904655","article-title":"Neuromyelitis optica spectrum disorder","volume":"387","author":"Wingerchuk","year":"2022","journal-title":"New Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s40635-023-00582-8","article-title":"Capillary leak and endothelial permeability in critically ill patients: a current overview","volume":"11","author":"Saravi","year":"2023","journal-title":"Intensive Care Med Exp"},{"key":"B3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.kint.2016.11.029","article-title":"Capillary leak syndrome: etiologies, pathophysiology, and management","volume":"92","author":"Siddall","year":"2017","journal-title":"Kidney Int"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2020.1774648","article-title":"Sj\u00f6gren\u2019s syndrome concurrent with organizing pneumonia with secondary systemic capillary leak syndrome: a case report","volume":"50","author":"Cao","year":"2021","journal-title":"Scand J Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e38104","DOI":"10.1097\/MD.0000000000038104","article-title":"Tocilizumab in the treatment of hyperferritinemic syndrome and capillary leak syndrome secondary to rheumatoid arthritis: Case report and literature review","volume":"103","author":"He","year":"2023","journal-title":"Medicine"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e2648","DOI":"10.1097\/MD.0000000000002648","article-title":"Antiphospholipids syndrome complicated by a systemic capillary leak-like syndrome treated with steroids and intravenous immunoglobulins: A case report","volume":"95","author":"Prete","year":"2016","journal-title":"Medicine"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e14370","DOI":"10.7759\/cureus.14370","article-title":"A rare case of idiopathic capillary leak syndrome","volume":"13","author":"Rao","year":"2021","journal-title":"Cureus"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e33404","DOI":"10.7759\/cureus.33404","article-title":"A case of capillary leak syndrome and intestinal ischemia caused by rheumatoid vasculitis","volume":"15","author":"Katsube","year":"2023","journal-title":"Cureus"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2017.06.001","article-title":"Capillary leak syndrome in neuromyelitis optica treated with rituximab","volume":"16","author":"Fuentes Fernandez","year":"2017","journal-title":"Mult Scler Relat Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2016.08.001","article-title":"Systemic capillary leak syndrome and autoimmune diseases: A case series","volume":"46","author":"Guffroy","year":"2017","journal-title":"Semin Arthritis Rheu"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2017.07.021","article-title":"Clinical presentation, management, and prognostic factors of idiopathic systemic capillary leak syndrome: A systematic review","volume":"6","author":"Eo","year":"2018","journal-title":"J Aller Cl Imm-Pract"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e50301","DOI":"10.7759\/cureus.50301","article-title":"Idiopathic systemic capillary leak syndrome: A clinical case","volume":"15","author":"Correia","year":"2023","journal-title":"Cureus"},{"key":"B13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13613-023-01165-2","article-title":"Angiopoietin-2 is associated with capillary leak and predicts complications after cardiac surgery","volume":"13","author":"Wollborn","year":"2023","journal-title":"Ann Intensive Care"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytac262","article-title":"Systemic leak capillary syndrome with myocardial involvement and cardiogenic shock: a case report","volume":"6","author":"Garatti","year":"2022","journal-title":"Eur Heart J Case Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41572-024-00571-5","article-title":"Systemic capillary leak syndrome","volume":"10","author":"Druey","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.06.049","article-title":"Systemic capillary leak syndrome secondary to coronavirus disease 2019","volume":"158","author":"Case","year":"2020","journal-title":"Chest"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e42837","DOI":"10.7759\/cureus.42837","article-title":"Systemic capillary leak syndrome as a rare, potentially fatal complication of COVID-19: A case report and literature review","volume":"15","author":"Naito","year":"2023","journal-title":"Cureus"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2022.02.014","article-title":"Anticancer drug-induced capillary leak syndrome","volume":"7","author":"Izzedine","year":"2022","journal-title":"Kidney Int Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-018-0306-5","article-title":"Capillary leak syndrome as a complication of antibody-mediated rejection treatment: a case report","volume":"7","author":"Ramirez-Sandoval","year":"2018","journal-title":"CEN Case Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2010.0159","article-title":"Idiopathic systemic capillary leak syndrome (Clarkson\u2019s disease): the Mayo clinic experience","volume":"85","author":"Kapoor","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/cells11121935","article-title":"Regulation and dysregulation of endothelial permeability during systemic inflammation","volume":"11","author":"Hellenthal","year":"2022","journal-title":"Cells"},{"key":"B22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41572-019-0069-0","article-title":"Acute respiratory distress syndrome","volume":"5","author":"Matthay","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001076","article-title":"New BBB model reveals that IL-6 blockade suppressed the BBB disorder, preventing onset of NMOSD","volume":"8","author":"Takeshita","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2014.882771","article-title":"Intravenous immunoglobulin in systemic capillary leak syndrome: a case report and review of literature","volume":"10","author":"Marra","year":"2014","journal-title":"Expert Rev Clin Immu"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.7326\/aimcc.2022.0496","article-title":"Management of acute episodes of clarkson disease (Monoclonal gammopathy-associated systemic capillary leak syndrome) with intravenous immunoglobulins","volume":"1","author":"Pecker","year":"2022","journal-title":"Ann Intern Med Clin Cases"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30078-8","article-title":"Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial","volume":"19","author":"Traboulsee","year":"2020","journal-title":"Lancet Neurol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3109\/00207454.2016.1163550","article-title":"Th17 cells in neuromyelitis optica spectrum disorder: a review","volume":"126","author":"Lin","year":"2016","journal-title":"Int J Neurosci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-021-00568-8","article-title":"Hope for patients with neuromyelitis optica spectrum disorders - from mechanisms to trials","volume":"17","author":"Pittock","year":"2021","journal-title":"Nat Rev Neurol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1684380\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T07:00:24Z","timestamp":1772607624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1684380\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":28,"alternative-id":["10.3389\/fimmu.2026.1684380"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1684380","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"article-number":"1684380"}}